Laura Anne Hatfield
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Anne Hatfield has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Christina Fu
Department of Health Care Policy, Harvard Medical School Boston Massachusetts USA
3 shared publicationsLisa M. Lix
Department of Community Health Sciences University of Manitoba Winnipeg Manitoba Canada
3 shared publications- Nicole Huang
National yang Ming Chiao Tung University
3 shared publications - Alan M. Zaslavsky
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
2 shared publications - Alyssa Bilinski
Departments of Health Policy and Biostatistics, Brown University
2 shared publications Amitava Banerjee
Institute of Health Informatics University College London London UK
2 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (8)
Unattributed Medicare beneficiaries have greater social disadvantage than those linked to primary care physicians
Introduction: Attributing patients to physicians using claims data is a key design feature of most payment and delivery models. However, claims-based attribution makes model participants less representative by excluding beneficiaries who use less care. Methods: We used the attribution methodology from the largest completed primary care model, Comprehensive Primary Care Plus (CPC+), to describe differences in attributable and unattributable Medicare beneficiaries living in CPC + regions from 2016 to 2021. Results: Unattributed beneficiaries were more male (56% vs 43%), eligible for the low-income drug subsidy (15% vs 12%), dual eligible (13% vs 10%), and non-White (22% vs 15%). Conclusion: Tests of models that use claims-based attribution may fail to generate evidence relevant to underserved groups. Policymakers should consider attribution designs that could improve representativeness of model test populations.
- 1 August 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (8)
Open AccessUnattributed Medicare beneficiaries have greater social disadvantage than those linked to primary care physicians
Introduction: Attributing patients to physicians using claims data is a key design feature of most payment and delivery models. However, claims-based attribution makes model participants less representative by excluding beneficiaries who use less care. Methods: We used the attribution methodology from the largest completed primary care model, Comprehensive Primary Care Plus (CPC+), to describe differences in attributable and unattributable Medicare beneficiaries living in CPC + regions from 2016 to 2021. Results: Unattributed beneficiaries were more male (56% vs 43%), eligible for the low-income drug subsidy (15% vs 12%), dual eligible (13% vs 10%), and non-White (22% vs 15%). Conclusion: Tests of models that use claims-based attribution may fail to generate evidence relevant to underserved groups. Policymakers should consider attribution designs that could improve representativeness of model test populations.
- 5 February 2026
- Published by Wiley in Statistics in Medicine
- Vol. 45 (3-5) , e70296
Nothing to See Here? A Non‐Inferiority Approach to Parallel Trends
Difference‐in‐differences is a popular method for observational health policy evaluation. It relies on a causal assumption that in the absence of intervention, treatment groups' outcomes would have evolved in parallel to those of comparison groups. Researchers frequently look for parallel trends in the pre‐intervention period to bolster confidence in this assumption. The popular “parallel trends test” evaluates a null hypothesis of parallel trends and, failing to find evidence against the null, concludes that the assumption holds. This tightly controls the probability of falsely concluding that trends are not parallel, but may have low power to detect non‐parallel trends. When used as a screening step, it can also introduce bias in treatment effect estimates. We propose a non‐inferiority/equivalence approach that tightly controls the probability of missing large violations of parallel trends, measured on the scale of the treatment effect. Our framework nests several common use cases, including linear trend tests and event studies. We show that our approach may induce no or minimal bias when used as a screening step under commonly assumed error structures and, absent violations, can offer a higher‐power alternative to testing treatment effects in more flexible models. We illustrate our ideas by reconsidering a study of the impact of the Affordable Care Act's dependent coverage provision.
- 5 February 2026
- Published by Wiley in Statistics in Medicine
- Vol. 45 (3-5) , e70296
Nothing to See Here? A Non‐Inferiority Approach to Parallel Trends
Difference‐in‐differences is a popular method for observational health policy evaluation. It relies on a causal assumption that in the absence of intervention, treatment groups' outcomes would have evolved in parallel to those of comparison groups. Researchers frequently look for parallel trends in the pre‐intervention period to bolster confidence in this assumption. The popular “parallel trends test” evaluates a null hypothesis of parallel trends and, failing to find evidence against the null, concludes that the assumption holds. This tightly controls the probability of falsely concluding that trends are not parallel, but may have low power to detect non‐parallel trends. When used as a screening step, it can also introduce bias in treatment effect estimates. We propose a non‐inferiority/equivalence approach that tightly controls the probability of missing large violations of parallel trends, measured on the scale of the treatment effect. Our framework nests several common use cases, including linear trend tests and event studies. We show that our approach may induce no or minimal bias when used as a screening step under commonly assumed error structures and, absent violations, can offer a higher‐power alternative to testing treatment effects in more flexible models. We illustrate our ideas by reconsidering a study of the impact of the Affordable Care Act's dependent coverage provision.
- Open Access
- 24 June 2025
- Published by Wiley in Health Services Research
- Vol. 60 (6) , e70002
Regionalization of Hip Fracture Care in Five High‐Income Countries
Objective: To describe differences in regionalization of hip fracture care and the volume‐outcome relationship in five countries. Study Setting and Design: We conducted a population‐based cross‐sectional cohort study in Canada, Israel, the Netherlands, Taiwan, and the United States. Within each country, we stratified patients into quintiles based upon the volume of hip fractures in the hospital where they were treated. We measured regionalization by the proportion of acute‐care hospitals that treated patients with hip fractures and summarized the hospital volume distribution by the ratio of hip fracture volumes for high‐volume hospitals versus low‐volume hospitals. We then examined age‐ and sex‐standardized outcomes and treatment for patients treated at high‐volume and low‐volume hospitals. Data Sources and Analytic Sample: We used nationally representative administrative data on adults aged ≥ 66 years hospitalized with hip fracture from 2011 to 2019. We followed them until death or 365 days after the discharge date. Principal Findings: Across countries, the percentage of all acute‐care hospitals that treated hip fractures differed widely (from 37.0% in Canada to 82.8% in Israel), with high‐volume hospitals treating 4–14 times as many hip fractures as low‐volume hospitals. The absolute risk‐adjusted difference in 30‐day mortality for high‐volume compared to low‐volume hospitals ranged between (−1.9% [95% CI, −2.2 to −1.7] in Canada and +1.1% [95% CI, 0.4–1.8] in the Netherlands). The proportion of patients receiving non‐operative fracture treatment was lower in high‐volume hospitals than low‐volume hospitals in all countries (−5.4% [95% CI, −6.5 to −4.3] in Israel to −0.1% [95% CI, −0.5 to 0.3] in the Netherlands). Conclusions: Hip fracture regionalization differed substantially across countries. The direction and the magnitude of association between greater regionalization and improved patient outcomes were inconsistent across countries.
- 24 June 2025
- Published by Wiley in Health Services Research
- Vol. 60 (6) , e70002
Open AccessRegionalization of Hip Fracture Care in Five High‐Income Countries
Objective: To describe differences in regionalization of hip fracture care and the volume‐outcome relationship in five countries. Study Setting and Design: We conducted a population‐based cross‐sectional cohort study in Canada, Israel, the Netherlands, Taiwan, and the United States. Within each country, we stratified patients into quintiles based upon the volume of hip fractures in the hospital where they were treated. We measured regionalization by the proportion of acute‐care hospitals that treated patients with hip fractures and summarized the hospital volume distribution by the ratio of hip fracture volumes for high‐volume hospitals versus low‐volume hospitals. We then examined age‐ and sex‐standardized outcomes and treatment for patients treated at high‐volume and low‐volume hospitals. Data Sources and Analytic Sample: We used nationally representative administrative data on adults aged ≥ 66 years hospitalized with hip fracture from 2011 to 2019. We followed them until death or 365 days after the discharge date. Principal Findings: Across countries, the percentage of all acute‐care hospitals that treated hip fractures differed widely (from 37.0% in Canada to 82.8% in Israel), with high‐volume hospitals treating 4–14 times as many hip fractures as low‐volume hospitals. The absolute risk‐adjusted difference in 30‐day mortality for high‐volume compared to low‐volume hospitals ranged between (−1.9% [95% CI, −2.2 to −1.7] in Canada and +1.1% [95% CI, 0.4–1.8] in the Netherlands). The proportion of patients receiving non‐operative fracture treatment was lower in high‐volume hospitals than low‐volume hospitals in all countries (−5.4% [95% CI, −6.5 to −4.3] in Israel to −0.1% [95% CI, −0.5 to 0.3] in the Netherlands). Conclusions: Hip fracture regionalization differed substantially across countries. The direction and the magnitude of association between greater regionalization and improved patient outcomes were inconsistent across countries.
- 27 May 2025
- Published by Wiley in Health Services Research
- Vol. 60 (5) , e14636
Time on Your Side: Aggregating Data in Difference‐In‐Differences Studies
Objective: To compare the performance of difference‐in‐differences estimators fit to data aggregated to different time scales.Study Setting and Design: In simulations, we generated monthly observations for 50–100 units over 6 years from both a parametric model and a resampling simulation. The simulation scenarios varied panel balance, treatment timing, and true treatment effects. Our target parameters were static and dynamic average effects of treatment on the treated (ATT) estimated via linear regression (for common timing scenarios) and Callaway and Sant'Anna (2021) estimators (for staggered timing scenarios). We compared estimates from monthly, quarterly, and yearly data using bias, standard error, root mean squared error (RMSE), power, and Type I error. We also conducted a case study to illustrate the real‐world impacts of these decisions.Data Sources and Analytic Sample: We used data from a study of police retraining for the resampling simulations and case study. These data included counts of use‐of‐force incidents and dates of training enrollment for 8614 officers each month from 2011 to 2016.Principal Findings: Results from the simulation varied across performance metrics, estimation methods, target estimands, and data structures. In general, the choice of time aggregation was more consequential when estimating dynamic (versus static) treatment effects, in unbalanced (versus balanced) panel data, and in the resampling simulations (where data had less autocorrelation). Although time aggregation mattered little in many scenarios, coarser aggregation was preferable in resampling simulations of staggered timing scenarios. The re‐analysis of police training data was sensitive to time aggregation.Conclusions: In many scenarios, time aggregation has little impact on difference‐in‐differences estimators. However, when estimating dynamic effects, especially in staggered timing settings and unbalanced data, we found a tradeoff between precision and power, with finer aggregations being more powerful but less precise. In addition, estimators that use a single reference time point are more sensitive to noise in data measured at finer time scales.
- 27 May 2025
- Published by Wiley in Health Services Research
- Vol. 60 (5) , e14636
Time on Your Side: Aggregating Data in Difference‐In‐Differences Studies
Objective: To compare the performance of difference‐in‐differences estimators fit to data aggregated to different time scales.Study Setting and Design: In simulations, we generated monthly observations for 50–100 units over 6 years from both a parametric model and a resampling simulation. The simulation scenarios varied panel balance, treatment timing, and true treatment effects. Our target parameters were static and dynamic average effects of treatment on the treated (ATT) estimated via linear regression (for common timing scenarios) and Callaway and Sant'Anna (2021) estimators (for staggered timing scenarios). We compared estimates from monthly, quarterly, and yearly data using bias, standard error, root mean squared error (RMSE), power, and Type I error. We also conducted a case study to illustrate the real‐world impacts of these decisions.Data Sources and Analytic Sample: We used data from a study of police retraining for the resampling simulations and case study. These data included counts of use‐of‐force incidents and dates of training enrollment for 8614 officers each month from 2011 to 2016.Principal Findings: Results from the simulation varied across performance metrics, estimation methods, target estimands, and data structures. In general, the choice of time aggregation was more consequential when estimating dynamic (versus static) treatment effects, in unbalanced (versus balanced) panel data, and in the resampling simulations (where data had less autocorrelation). Although time aggregation mattered little in many scenarios, coarser aggregation was preferable in resampling simulations of staggered timing scenarios. The re‐analysis of police training data was sensitive to time aggregation.Conclusions: In many scenarios, time aggregation has little impact on difference‐in‐differences estimators. However, when estimating dynamic effects, especially in staggered timing settings and unbalanced data, we found a tradeoff between precision and power, with finer aggregations being more powerful but less precise. In addition, estimators that use a single reference time point are more sensitive to noise in data measured at finer time scales.
- 12 May 2025
- Published by Wiley in Health Services Research
- Vol. 60 (5) , e14635
State Bans on Sexual Orientation and Gender Identity Change Efforts and Youth Suicidality
Objective: To assess the impact of state legislation banning healthcare workers from using sexual orientation and gender identity change efforts with minors (attempts to convert sexual and gender diverse individuals to be heterosexual and/or cisgender; also known as “conversion therapies”) on adolescent suicidality.Study Setting and Design: We used high school student responses to the 2011–2019 Youth Risk Behavior Survey. Using a quasi‐experimental stacked difference‐in‐differences (DID) approach, we estimated the association between bans and rates of seriously considering suicide in the past year. In states that included sexual orientation survey questions, we assessed the association between bans and considering suicide for sexual minority and heterosexual youth.Data Sources and Analytic Sample: Retrospective analysis of 181,950 youth across four treatment states (Illinois, Connecticut, Rhode Island, and Maryland) and 240,268 youth across 25 control states. Treatment states included those that: (1) passed bans during the study period, (2) passed bans independent of antibullying and nondiscrimination laws, and (3) participated in the Youth Risk Behavior Survey for one wave before and one wave after passing a ban. For secondary analyses by sexual identity, 11 control states were available.Principal Findings: Among respondents, 17% reported seriously considering suicide in the prior year. In the 2 years following sexual orientation and gender identity change effort bans, rates of considering suicide were 2.9 percentage points lower (95% CI: −4.2, −1.6) in states with bans compared to control states. Improvements appeared to be larger for lesbian, gay, and bisexual youth (4.6 percentage point reduction; 95% CI: −6.4, −2.8) than for heterosexual youth. Reductions were statistically significant in Illinois, Connecticut, and Rhode Island compared to control states, but not in Maryland.Conclusions: State laws banning sexual orientation and gender identity change efforts by healthcare providers for minors were associated with reduced rates of considering suicide among high school students.
- 12 May 2025
- Published by Wiley in Health Services Research
- Vol. 60 (5) , e14635
State Bans on Sexual Orientation and Gender Identity Change Efforts and Youth Suicidality
Objective: To assess the impact of state legislation banning healthcare workers from using sexual orientation and gender identity change efforts with minors (attempts to convert sexual and gender diverse individuals to be heterosexual and/or cisgender; also known as “conversion therapies”) on adolescent suicidality.Study Setting and Design: We used high school student responses to the 2011–2019 Youth Risk Behavior Survey. Using a quasi‐experimental stacked difference‐in‐differences (DID) approach, we estimated the association between bans and rates of seriously considering suicide in the past year. In states that included sexual orientation survey questions, we assessed the association between bans and considering suicide for sexual minority and heterosexual youth.Data Sources and Analytic Sample: Retrospective analysis of 181,950 youth across four treatment states (Illinois, Connecticut, Rhode Island, and Maryland) and 240,268 youth across 25 control states. Treatment states included those that: (1) passed bans during the study period, (2) passed bans independent of antibullying and nondiscrimination laws, and (3) participated in the Youth Risk Behavior Survey for one wave before and one wave after passing a ban. For secondary analyses by sexual identity, 11 control states were available.Principal Findings: Among respondents, 17% reported seriously considering suicide in the prior year. In the 2 years following sexual orientation and gender identity change effort bans, rates of considering suicide were 2.9 percentage points lower (95% CI: −4.2, −1.6) in states with bans compared to control states. Improvements appeared to be larger for lesbian, gay, and bisexual youth (4.6 percentage point reduction; 95% CI: −6.4, −2.8) than for heterosexual youth. Reductions were statistically significant in Illinois, Connecticut, and Rhode Island compared to control states, but not in Maryland.Conclusions: State laws banning sexual orientation and gender identity change efforts by healthcare providers for minors were associated with reduced rates of considering suicide among high school students.
- 10 March 2025
- Published by The R Foundation
apm: Averaged Prediction Models
In panel data settings, specifies set of candidate models, fits them to data from pre-treatment validation periods, and selects model as average over candidate models, weighting each by posterior probability of being most robust given its differential average prediction errors in pre-treatment validation periods. Subsequent estimation and inference of causal effect's bounds accounts for both model and sampling uncertainty, and calculates the robustness changepoint value at which bounds go from excluding to including 0. The package also includes a range of diagnostic plots, such as those illustrating models' differential average prediction errors and the posterior distribution of which model is most robust.
- 10 March 2025
- Published by The R Foundation
apm: Averaged Prediction Models
In panel data settings, specifies set of candidate models, fits them to data from pre-treatment validation periods, and selects model as average over candidate models, weighting each by posterior probability of being most robust given its differential average prediction errors in pre-treatment validation periods. Subsequent estimation and inference of causal effect's bounds accounts for both model and sampling uncertainty, and calculates the robustness changepoint value at which bounds go from excluding to including 0. The package also includes a range of diagnostic plots, such as those illustrating models' differential average prediction errors and the posterior distribution of which model is most robust.
- 19 December 2024
- Published by Wiley in Health Services Research
- Vol. 60 (S2) , e14419
Transporting difference‐in‐differences estimates to assess health equity impacts of payment and delivery models
Objective: To demonstrate the use of transportability methods to extend findings from payment model evaluations to groups of historically underserved beneficiaries.Study Setting and Design: We used a simulation study to transport the effects of the Comprehensive Primary Care Plus (CPC+) model to a target population of Black fee‐for‐service (FFS) Medicare beneficiaries living outside the original 18 CPC+ regions. Our main outcome variable was total Medicare spending per beneficiary per year (pbpy).Data Sources and Analytic Sample: We simulated practice‐level spending in 18 CPC+ regions and 32 non‐CPC+ regions (1200 practices per region). We calibrated the simulation parameters to values from the literature and then varied four key parameters to create 16 realistic simulation scenarios. These scenarios varied the representativeness of practices in CPC+ regions that joined CPC+ (i.e., the sample) relative to the target population by changing the distribution of Black beneficiaries across practices and the distribution of practices across regions. Practices were characterized by their experience with the Medicare Shared Savings Program (SSP) and system/hospital ownership because these are known to modify the effect of CPC+ on spending.Principal Findings: Across the 16 simulation scenarios, transporting the treatment effect of CPC+ to Black FFS beneficiaries in non‐CPC+ regions yielded median treatment effects that ranged from $15.5 pbpy smaller to $10 pbpy larger than in the sample. These differences are roughly the same magnitude as the estimated overall effect of $13 pbpy.Conclusions: The Center for Medicare and Medicaid Innovation has pledged to put equity at the center of its demonstration models. However, offering models in limited geographic areas with voluntary provider participation may result in unrepresentative samples. Naively generalizing CPC+ effects from geographically limited, voluntary samples to all Black FFS beneficiaries could be misleading. Under some circumstances, transportability methods can be used to estimate effects in this target population.
- 19 December 2024
- Published by Wiley in Health Services Research
- Vol. 60 (S2) , e14419
Transporting difference‐in‐differences estimates to assess health equity impacts of payment and delivery models
Objective: To demonstrate the use of transportability methods to extend findings from payment model evaluations to groups of historically underserved beneficiaries.Study Setting and Design: We used a simulation study to transport the effects of the Comprehensive Primary Care Plus (CPC+) model to a target population of Black fee‐for‐service (FFS) Medicare beneficiaries living outside the original 18 CPC+ regions. Our main outcome variable was total Medicare spending per beneficiary per year (pbpy).Data Sources and Analytic Sample: We simulated practice‐level spending in 18 CPC+ regions and 32 non‐CPC+ regions (1200 practices per region). We calibrated the simulation parameters to values from the literature and then varied four key parameters to create 16 realistic simulation scenarios. These scenarios varied the representativeness of practices in CPC+ regions that joined CPC+ (i.e., the sample) relative to the target population by changing the distribution of Black beneficiaries across practices and the distribution of practices across regions. Practices were characterized by their experience with the Medicare Shared Savings Program (SSP) and system/hospital ownership because these are known to modify the effect of CPC+ on spending.Principal Findings: Across the 16 simulation scenarios, transporting the treatment effect of CPC+ to Black FFS beneficiaries in non‐CPC+ regions yielded median treatment effects that ranged from $15.5 pbpy smaller to $10 pbpy larger than in the sample. These differences are roughly the same magnitude as the estimated overall effect of $13 pbpy.Conclusions: The Center for Medicare and Medicaid Innovation has pledged to put equity at the center of its demonstration models. However, offering models in limited geographic areas with voluntary provider participation may result in unrepresentative samples. Naively generalizing CPC+ effects from geographically limited, voluntary samples to all Black FFS beneficiaries could be misleading. Under some circumstances, transportability methods can be used to estimate effects in this target population.
- 17 June 2024
- Published by Springer Nature in Health Services and Outcomes Research Methodology
- Vol. 25 (2) , 166-181
Markets matter: a simulation study of the bias-variance trade-off in comparison group selection for difference-in-differences analysis
- 17 June 2024
- Published by Springer Nature in Health Services and Outcomes Research Methodology
- Vol. 25 (2) , 166-181
Markets matter: a simulation study of the bias-variance trade-off in comparison group selection for difference-in-differences analysis
- 1 March 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (3) , e010144
Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative
BACKGROUND: Sex differences in acute myocardial infarction treatment and outcomes are well documented, but it is unclear whether differences are consistent across countries. The objective of this study was to investigate the epidemiology, use of interventional procedures, and outcomes for older females and males hospitalized with ST-segment–elevation myocardial infarction (STEMI) and non–ST-segment–elevation myocardial infarction (NSTEMI) in 6 diverse countries. METHODS: We conducted a serial cross-sectional cohort study of 1 508 205 adults aged ≥66 years hospitalized with STEMI and NSTEMI between 2011 and 2018 in the United States, Canada, England, the Netherlands, Taiwan, and Israel using administrative data. We compared females and males within each country with respect to age-standardized hospitalization rates, rates of cardiac catheterization, percutaneous coronary intervention, and coronary artery bypass graft surgery within 90 days of hospitalization, and 30-day age- and comorbidity-adjusted mortality. RESULTS: Hospitalization rates for STEMI and NSTEMI decreased between 2011 and 2018 in all countries, although the hospitalization rate ratio (rate in males/rate in females) increased in virtually all countries (eg, US STEMI ratio, 1.58:1 in 2011 and 1.73:1 in 2018; Israel NSTEMI ratio, 1.71:1 in 2011 and 2.11:1 in 2018). Rates of cardiac catheterization, percutaneous coronary intervention, and coronary artery bypass graft surgery were lower for females than males for STEMI in all countries and years (eg, US cardiac catheterization in 2018, 88.6% for females versus 91.5% for males; Israel percutaneous coronary intervention in 2018, 76.7% for females versus 84.8% for males) with similar findings for NSTEMI. Adjusted mortality for STEMI in 2018 was higher for females than males in 5 countries (the United States, Canada, the Netherlands, Israel, and Taiwan) but lower for females than males in 5 countries for NSTEMI. CONCLUSIONS: We observed a larger decline in acute myocardial infarction hospitalizations for females than males between 2011 and 2018. Females were less likely to receive cardiac interventions and had higher mortality after STEMI. Sex disparities seem to transcend borders, raising questions about the underlying causes and remedies.
- 1 March 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (3) , e010144
Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative
BACKGROUND: Sex differences in acute myocardial infarction treatment and outcomes are well documented, but it is unclear whether differences are consistent across countries. The objective of this study was to investigate the epidemiology, use of interventional procedures, and outcomes for older females and males hospitalized with ST-segment–elevation myocardial infarction (STEMI) and non–ST-segment–elevation myocardial infarction (NSTEMI) in 6 diverse countries. METHODS: We conducted a serial cross-sectional cohort study of 1 508 205 adults aged ≥66 years hospitalized with STEMI and NSTEMI between 2011 and 2018 in the United States, Canada, England, the Netherlands, Taiwan, and Israel using administrative data. We compared females and males within each country with respect to age-standardized hospitalization rates, rates of cardiac catheterization, percutaneous coronary intervention, and coronary artery bypass graft surgery within 90 days of hospitalization, and 30-day age- and comorbidity-adjusted mortality. RESULTS: Hospitalization rates for STEMI and NSTEMI decreased between 2011 and 2018 in all countries, although the hospitalization rate ratio (rate in males/rate in females) increased in virtually all countries (eg, US STEMI ratio, 1.58:1 in 2011 and 1.73:1 in 2018; Israel NSTEMI ratio, 1.71:1 in 2011 and 2.11:1 in 2018). Rates of cardiac catheterization, percutaneous coronary intervention, and coronary artery bypass graft surgery were lower for females than males for STEMI in all countries and years (eg, US cardiac catheterization in 2018, 88.6% for females versus 91.5% for males; Israel percutaneous coronary intervention in 2018, 76.7% for females versus 84.8% for males) with similar findings for NSTEMI. Adjusted mortality for STEMI in 2018 was higher for females than males in 5 countries (the United States, Canada, the Netherlands, Israel, and Taiwan) but lower for females than males in 5 countries for NSTEMI. CONCLUSIONS: We observed a larger decline in acute myocardial infarction hospitalizations for females than males between 2011 and 2018. Females were less likely to receive cardiac interventions and had higher mortality after STEMI. Sex disparities seem to transcend borders, raising questions about the underlying causes and remedies.
- 27 February 2024
- Published by American Medical Association (AMA) in JAMA
- Vol. 331 (8) , 652-653
Trickle-Down Medicaid
The Affordable Care Act (ACA) sought to expand Medicaid to all adults with incomes less than 138% of the federal poverty level. However, because Medicaid is a
- 27 February 2024
- Published by American Medical Association (AMA) in JAMA
- Vol. 331 (8) , 652-653
Trickle-Down Medicaid
The Affordable Care Act (ACA) sought to expand Medicaid to all adults with incomes less than 138% of the federal poverty level. However, because Medicaid is a